Published in Mol Cell Biol on February 01, 1999
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A (2004) 12.30
ATP-dependent chromatin-remodeling complexes. Mol Cell Biol (2000) 5.07
The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol (2001) 2.76
Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J (2003) 2.34
Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol (2001) 2.26
Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol (2002) 2.15
Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene. Mol Cell Biol (2000) 2.10
Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev (2000) 2.07
Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell (2007) 2.07
Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene (2007) 1.92
Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol (2004) 1.82
BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol (2004) 1.57
A genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics (1999) 1.51
The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol Cell Biol (1999) 1.48
SWI/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genet (2009) 1.22
A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr Cancer Drug Targets (2004) 1.16
The human brm protein is cleaved during apoptosis: the role of cathepsin G. Proc Natl Acad Sci U S A (2001) 1.10
Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation. EMBO J (2003) 1.10
LKB1, the multitasking tumour suppressor kinase. J Clin Pathol (2005) 1.07
Epigenetic control of aging. Antioxid Redox Signal (2010) 1.02
Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics (2011) 1.01
Drosophila cyclin E interacts with components of the Brahma complex. EMBO J (2002) 1.00
BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One (2013) 0.98
AtSWI3B, an Arabidopsis homolog of SWI3, a core subunit of yeast Swi/Snf chromatin remodeling complex, interacts with FCA, a regulator of flowering time. Nucleic Acids Res (2002) 0.98
The Drosophila SNR1 (SNF5/INI1) subunit directs essential developmental functions of the Brahma chromatin remodeling complex. Mol Cell Biol (2003) 0.96
The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner. PLoS One (2012) 0.94
The rb pathway and cancer therapeutics. Curr Drug Targets (2009) 0.93
Nuclear shape changes are induced by knockdown of the SWI/SNF ATPase BRG1 and are independent of cytoskeletal connections. PLoS One (2013) 0.92
Varying modulation of HIV-1 LTR activity by Baf complexes. J Mol Biol (2011) 0.92
Binding of polyomavirus small T antigen to protein phosphatase 2A is required for elimination of p27 and support of S-phase induction in concert with large T antigen. J Virol (1999) 0.91
BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes. Mol Cell Biol (2013) 0.91
Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int J Exp Pathol (2001) 0.90
The Drosophila gene taranis encodes a novel trithorax group member potentially linked to the cell cycle regulatory apparatus. Genetics (2002) 0.89
Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics (2008) 0.89
Gene silencing associated with SWI/SNF complex loss during NSCLC development. Mol Cancer Res (2014) 0.87
Chapter 5. Nuclear actin-related proteins in epigenetic control. Int Rev Cell Mol Biol (2009) 0.85
A unique missense allele of BAF155, a core BAF chromatin remodeling complex protein, causes neural tube closure defects in mice. Dev Neurobiol (2014) 0.84
SNR1 (INI1/SNF5) mediates important cell growth functions of the Drosophila Brahma (SWI/SNF) chromatin remodeling complex. Genetics (2004) 0.83
Differential control of transcription by DNA-bound cyclins. Mol Biol Cell (2001) 0.82
Constraint-based analysis of gene interactions using restricted boolean networks and time-series data. BMC Proc (2011) 0.81
The chromatin-remodeling protein Osa interacts with CyclinE in Drosophila eye imaginal discs. Genetics (2009) 0.80
miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators. Oncotarget (2016) 0.77
BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness. PLoS One (2017) 0.75
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Cancer cell cycles. Science (1996) 21.29
Principles of CDK regulation. Nature (1995) 13.09
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19
Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science (1994) 7.17
Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature (1994) 6.55
BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature (1993) 6.41
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol (1995) 6.41
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (1992) 6.40
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
RSC, an essential, abundant chromatin-remodeling complex. Cell (1996) 6.17
Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev (1996) 6.01
Association of human cyclin E with a periodic G1-S phase protein kinase. Science (1992) 5.98
Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature (1994) 5.95
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47
Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31
A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J (1993) 5.26
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell (1994) 5.00
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci (1995) 4.20
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol (1994) 3.16
E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev (1994) 3.05
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99
Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J (1994) 2.95
Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev (1998) 2.93
G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell (1991) 2.87
Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81
The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J (1996) 2.71
Persistent site-specific remodeling of a nucleosome array by transient action of the SWI/SNF complex. Science (1996) 2.63
Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state. Cell (1998) 2.63
Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J (1994) 2.61
RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A (1997) 2.53
Catalytic activity of the yeast SWI/SNF complex on reconstituted nucleosome arrays. EMBO J (1997) 2.48
Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol (1998) 2.42
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
Activated RSC-nucleosome complex and persistently altered form of the nucleosome. Cell (1998) 2.38
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26
Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol (1996) 2.23
Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev (1998) 2.14
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res (1995) 1.92
Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J (1997) 1.81
Sfh1p, a component of a novel chromatin-remodeling complex, is required for cell cycle progression. Mol Cell Biol (1997) 1.73
Cyclin dependent kinase regulation. Curr Opin Cell Biol (1995) 1.70
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr Biol (1997) 1.48
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J Virol (1993) 1.29
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell (1994) 7.05
Association of human cyclin E with a periodic G1-S phase protein kinase. Science (1992) 5.98
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol (1997) 4.36
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol (1998) 3.45
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med (1992) 3.30
Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature (1999) 3.24
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res (2000) 3.01
The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene (1994) 2.55
NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol Cell (1998) 2.33
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30
The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene (2000) 2.15
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene (1994) 1.99
A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A (1994) 1.95
Complex structure and regulation of the P16 (MTS1) locus. Cancer Res (1995) 1.87
Helminth infestations in immigrant children. Br Med J (1965) 1.87
Cyclin E, a potential prognostic marker for breast cancer. Cancer Res (1994) 1.82
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation. Mol Cell Biol (2001) 1.70
Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene (1999) 1.64
Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem (2001) 1.63
Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol (1999) 1.58
Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene (1996) 1.58
Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer (1996) 1.57
Vestibular schwannoma (acoustic neuroma). Consensus development conference. Neurosurgery (1992) 1.55
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood (1992) 1.53
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. J Virol (1994) 1.46
Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer (2003) 1.44
A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells. Mol Cell Biol (1999) 1.34
The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol (1989) 1.34
Binding and recognition of GATATC target sequences by the EcoRV restriction endonuclease: a study using fluorescent oligonucleotides and fluorescence polarization. Biochemistry (2001) 1.33
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int Immunol (2000) 1.33
Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res (1995) 1.32
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J Virol (1993) 1.29
Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene (1997) 1.27
Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene (1998) 1.24
Direct and continuous assessment by cells of their position in a morphogen gradient. Nature (1995) 1.22
Murine PGK-1 promoter drives widespread but not uniform expression in transgenic mice. Dev Dyn (1994) 1.21
Efficacy of hepatitis B vaccine. J Soc Occup Med (1988) 1.19
Bifrontal decompressive craniectomy in the management of posttraumatic intracranial hypertension. Br J Neurosurg (2001) 1.16
Cyclin D3 is essential for megakaryocytopoiesis. Blood (1995) 1.15
Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel-12 and hop-1 in Notch-pathway signaling. Proc Natl Acad Sci U S A (1999) 1.14
Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J Exp Med (1996) 1.08
Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg (1998) 1.07
Iron chelation as a chemotherapeutic strategy for falciparum malaria. Am J Trop Med Hyg (1993) 0.94
Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population. J Med Econ (2010) 0.92
Actinomycosis associated with pilonidal sinus of the penis. J Urol (1992) 0.92
Antibody production by lymph-borne immunoblasts following subcutaneous injection into xenogeneic recipients. Immunology (1971) 0.91
Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J Exp Med (1998) 0.91
The use of a moulded metacarpal brace versus neighbour strapping for fractures of the little finger metacarpal neck. J Hand Surg Br (2001) 0.90
Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol (2000) 0.90
Expression of laminin subunits in congenital muscular dystrophy. Neuromuscul Disord (1995) 0.89
Decision making, beliefs, and attitudes toward hysterectomy: a focus group study with medically underserved women in Texas. J Womens Health Gend Based Med (2000) 0.87
Identification of oenanthotoxin and related compounds in hemlock water dropwort poisoning. Hum Toxicol (1985) 0.87
Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review. Health Technol Assess (2001) 0.86
SEB-3, a CRF receptor-like GPCR, regulates locomotor activity states, stress responses and ethanol tolerance in Caenorhabditis elegans. Genes Brain Behav (2012) 0.85
New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results. J Med Chem (1985) 0.83
Changes in poly(a)+ RNA during male meiosis in Lilium. J Cell Sci (1983) 0.83
Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Am J Trop Med Hyg (1998) 0.83
Ischaemic sciatic neuropathy: an important complication of embolisation of a type II endoleak. Eur J Vasc Endovasc Surg (2002) 0.81
Hysterectomy: beliefs and attitudes expressed by African-American women. Ethn Dis (2001) 0.80
Probing the membrane topology of Candida tropicalis cytochrome P450. Eur J Biochem (1993) 0.80
A study of the brightness of laryngoscope light. Anaesthesia (1996) 0.79
Predictors of severity of illness on presentation in children with cerebral malaria. Ann Trop Med Parasitol (1995) 0.79
Non-target effects of transgenic blight-resistant American chestnut (Fagales: Fagaceae) on insect herbivores. Environ Entomol (2011) 0.78
Effects of water hardness and alkalinity on the toxicity of uranium to a tropical freshwater hydra (Hydra viridissima). Biomarkers (2001) 0.78
Marked variation in peritoneal insulin absorption in peritoneal dialysis. Perit Dial Int (2001) 0.78
The cost-effectiveness of magnetic resonance imaging for investigation of the knee joint. Health Technol Assess (2001) 0.78
Assay of restriction endonucleases using oligonucleotides. Methods Mol Biol (2001) 0.78
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents. Nucl Med Biol (1995) 0.78
Screening for abuse: barriers and opportunities. Health Care Women Int (2001) 0.77
Ultrastructural and enzymatic development of fetal guinea pig heart. Am J Physiol (1982) 0.77
Induction of labour for post term pregnancy: an observational study. Aust N Z J Obstet Gynaecol (1998) 0.76
A comparison of the effect of elemental and immune-enhancing polymeric jejunal feeding on exocrine pancreatic function. JPEN J Parenter Enteral Nutr (2002) 0.76
The Patient Care Notebook: quality improvement on a rehabilitation unit. Jt Comm J Qual Improv (2001) 0.76
The Origin of Multiple Crossover Chromatids in Short Genetic Intervals in DROSOPHILA MELANOGASTER. Genetics (1966) 0.76
Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2. Leukemia (1997) 0.76
A study of radionuclides, metals and stable lead isotope ratios in sediments and soils in the vicinity of natural U-mineralisation areas in the Northern Territory. J Environ Radioact (2010) 0.76
Monitoring clinical trials. Several points are contentious. BMJ (2001) 0.75
Let's lose the tie. J Hosp Infect (2001) 0.75
A prospective study of combination antimalarial therapy and of anaemia in Zambian children with cerebral malaria. Ann Trop Med Parasitol (1999) 0.75
Housing the disabled. Dist Nurs (1969) 0.75
When one is two. J Burn Care Rehabil (1999) 0.75
Cholecystostomy. Br J Surg (1976) 0.75
Claiming innocence and determined to nurse again. Interview by Sharon Watson. Nurs Stand (1998) 0.75